A randomised double-blind trial in post-menopausal women with primary breast cancer who have received adjuvant tamoxifen for 2-3 years, comparing subsequent adjuvant exemestane treatment with further tamoxifen

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2002
This article has no abstract
Epistemonikos ID: 682dcf06976532c5e753dcc0a8a7ea3892c5778a
First added on: Jan 16, 2025